European Commission approves Merck acquisition of Millipore
The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck.
The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck. The $7.2 billion acquisition was announced in March and this approval keeps it on course for completion later this year.
The commission ruled that although the parties are both active in the life science business, they focus on different markets. In a statement they said that while Millipore supplies inputs for the research, development and production of biological drugs created through biological processes, Merck's inputs mainly serve in the research, development and production of products created through chemical processes. It concluded, “the transaction is largely complementary.”
For more information on the companies visit their websites, www.merck.de and www.millipore.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities
January 14th 2025This application note demonstrates a liquid chromatography/quadrupole time-of-flight mass spectrometer (LC/Q-TOF MS) workflow for the identification and characterization of therapeutic peptides.
